KO vs STRO
The Coca-Cola Company (KO) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
KO currently screens at market cap $343.90B and trailing P/E 25.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the KO and STRO stock pages for the full models.
Not investment advice.